Send the following on WhatsApp
Continue to ChatUpdated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib - https://avesis.istanbul.edu.tr/yayin/d1d4941b-12b2-4bd5-846e-271cf19c093d/updated-efficacy-and-safety-and-exploratory-ki-67-results-for-the-mcl-001-study-of-lenalidomide-in-mantle-cell-lymphoma-patients-who-relapsed-or-were-refractory-to-bortezomib